Mississauga, ON | 21 January 2025 Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is pleased to announce the approval of RayOne EMV Toric (RAO210T) by Health Canada. Developed in collaboration with Professor Graham Barrett, RayOne EMV and RayOne EMV Toric are the only patented aspheric IOLs that induce controlled

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study for the EMV Toric Intraocular lens in the USA. The study reflects Rayner’s continued focus on optimising visual outcomes for surgeons and their patients and

16 September 2022. Worthing, United Kingdom – Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, today announced that the world’s first implantations of RayOne EMV Toric had been performed by two highly respected surgeons from the UK. RayOne EMV Toric is the awaited toric variant of Rayner’s popular RayOne

Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing

Rayner will offer the most complete family of trifocal IOLs in the industry, allowing surgeons to treat an even wider range of presbyopic patients: Sulcoflex Trifocal, RayOne Trifocal and new RayOne Trifocal Toric. High patient satisfaction and spectacle independence reported from a multicentre pilot study. RayOne Trifocal Toric’s cylinder range starts from +0.75 D, allowing

6 May 2025 Rayner, a global provider of solutions for cataract surgery and the only manufacturer of intraocular lenses (IOLs) in the UK, proudly announces today that it has been honoured with the prestigious King’s Award for Enterprise 2025 for its innovative RayOne EMV increased range of focus IOL. RayOne EMV, which launched in 2020,

02 April 2025 | In response to demand growth, Rayner – a global leader in solutions for cataract surgery – has completed an extensive expansion of its Worthing (UK) production facility, doubling the number of intraocular lenses (IOLs) it can manufacture annually to 4 million. Since opening its purpose-built manufacturing facility in 2017, every Rayner

In September 2024, Rayner – a global manufacturer of products for cataract surgery based in the UK – unveiled the world’s first spiral IOL at the ESCRS congress in Barcelona. Today, following a large-scale multicentre data collection study, Rayner announces the full commercial release of RayOne Galaxy and RayOne Galaxy Toric, marking a wider global

Rayner, a global manufacturer of products for cataract surgery, today announces the launch of its redesigned online premium IOL calculator, RayTrace. One of the first online IOL calculation tools, RayTrace has been trusted by surgeons globally since 2008 for the accuracy of its premium IOL (toric, multifocal and supplementary) calculations, and has delivered over 360,000

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, today announces the upcoming launch of the world’s first spiral IOL designed with artificial intelligence: RayOne Galaxy and Galaxy Toric. Launching at this year’s ESCRS Congress in Barcelona, the RayOne Galaxy IOL comes to market precisely 75 years after Rayner pioneered the

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, proudly announces delivery of its 5 millionth RayOne lens (and 11 millionth lens made from RayAcryl Rayner’s proprietary hydrophilic acrylic material), marking an important milestone in units sold globally. RayOne is Rayner’s fully-preloaded intraocular lens (IOL) injection system, providing smooth, consistent rolling

Worthing, United Kingdom – August 11, 2023: Rayner, a global ophthalmic leader in Devices, Drugs and Digital, is pleased to announce the successful completion of the first implantations in two pivotal market access studies in China and the USA. In April, Rayner received approval from the People’s Republic of China’s Ministry of Science and Technology

Rayner, a renowned global leader in innovative ophthalmic solutions and the pioneering manufacturer of the world’s first intraocular lens (IOL) in 1949, proudly announces a significant achievement in their ongoing dedication to improving vision. Last month, the company celebrates the successful implantation of their 4 millionth RayOne IOL, underscoring their commitment to advancing eye care

The first seven episodes of ‘Peer2Peer: The Podcast’ are now available, featuring Dr Lisa Nijm (USA), Dr Paul Singh (USA), Dr Stefanie Schmickler (Germany), Dr Josefina Botta (Argentina), Dr Karl Stonecipher (USA), Professor Graham Barrett (Australia), Mr Paul Rosen (UK), Mr Allon Barsam (UK), Mr Andrew Turnbull (UK), Dr Eric Donnenfeld (USA) and Dr Jerry

Rayner sponsors ESCRS satellite symposium When: Sunday 18th September, 13.00-14.00 Where: Room Blue 2 Professor Oliver Findl (Austria), Professor Gerd Auffarth (Germany), Mr Allon Barsam (United Kingdom), Dr Başak Bostanci (Turkey) and Dr Tiago Ferreira (Portugal) complete the panel of surgeons for the Rayner-sponsored satellite symposium: Challenges in cataract surgery and advanced technology IOL solutions.

JANUARY 19, 2022 – Worthing, United Kingdom. Rayner, a leading ophthalmology company and the only British manufacturer of intraocular lenses (IOLs), announced today that it now has a direct sales presence in Australia as it continues its global commercial expansion. Previously distributed through Designs For Vision, Rayner will now sell its products directly to surgeons and hospitals

DECEMBER 22, 2021 – Worthing, United Kingdom. Rayner, a leading UK-based ophthalmic company focused on optimising visual outcomes for surgeons and their patients, is delighted to announce the appointment of Drs Eric Donnenfeld, Kerry Solomon, Vance Thompson, and Mr Jim Mazzo as strategic advisors to the business, with a specific focus on supporting the expansion

Worthing, UK, 3 May 2021 – With the global rollout of the RayOne EMV™ intraocular lens to markets around the world, Rayner announces today an exciting new campaign intended to extoll the benefits of monovision (including “Mini”, “Micro”, or “Blended”). The Plus1 EMV: A global discussion on Enhanced Monovision™ campaign will shine a light on

Worthing, UK – Following the recent approval of incorporation, Rayner is proud to announce its direct entry into the Canadian ophthalmology market. Led by Wade Allen, Director: Americas, Rayner Surgical Corp will now be offering the Rayner portfolio of IOLs and injectors directly to Canadian surgeons. Rayner Surgical Corp has recently had the RayOne Aspheric

Worthing (UK) – Rayner, the manufacturer of the world’s first intraocular lens (IOL) and winner of the 2020 Queen’s Award for Enterprise (Innovation), announced today the launch of their updated web-based Premium IOL Calculator, Raytrace. Developed in line with surgeon feedback, the new Raytrace version 3.5 includes the following improvements: Inclusion of Posterior Corneal Astigmatism

Rayner set to launch RayOne EMV in early October Worthing, UK, September 21st, 2020 – Rayner has announced the upcoming launch of RayOne EMV: a new fully preloaded non-diffractive IOL solution designed specifically to enhance patient outcomes achieved with monovision. Enhanced range of vision Developed in collaboration with Professor Graham Barrett, president of the Australasian

Rayner hosted its first surgeon clinical education webinar on 27 May 2020, with attendees from over 47 countries. Over the course of one hour, the three presenters spoke about returning to clinic (including associated safety precautions), their experience with premium trifocal IOLs, and the utilisation of contactless telehealth. The webinar was concluded with a busy

Wednesday 27th May (1 hour) Join an international panel of expert speakers as they share their experiences with premium trifocal intraocular lenses (IOLs), and discuss the importance of Patient Reported Outcomes (PROs). The speakers will also talk about returning to clinic after COVID-19. The webinar will last 1 hour (includes 15-minute Question & Answer session).

For Immediate Release Date: 7th August 2018 Rayner are proud to announce the launch of the new, CE marked Sulcoflex Trifocal Pseudophakic Supplementary IOL at the 2018 ESCRS in Vienna. Rayner’s most technologically advanced IOL The Sulcoflex Trifocal combines Rayner’s pseudophakic supplementary Sulcoflex platform — designed to be implanted in the ciliary sulcus and with over ten

RayOne Hydrophobic, Rayner’s first fully preloaded IOL system with a hydrophobic acrylic lens, is now available to CE Mark-accepting countries. Daily compromises faced by cataract surgeons are eliminated with a new proprietary material, unique Cornerstone lens shape and intuitive fully preloaded injector. Worthing (UK), May 22nd, 2018 – Rayner, the manufacturer of the world’s first IOL,

For immediate release. Date: 05 March, 2018. RayOne Fully Preloaded IOL injection system now available in Argentina Rayner, together with Iskowitz – Rayner’s exclusive distributor in Argentina — announced today that the RayOne fully preloaded IOL injection system has received approval from the Argentine regulator, ‘Administración Nacional de Medicamentos, Alimentos y Tecnología Médica’ (ANMAT), and is now

For immediate release Ten year milestones achieved for key Primary & Supplementary IOLs. 2017 in review. 18th January, 2018. Worthing, United Kingdom. Over the course of 2017, Rayner marked the ten year anniversary for receiving CE approval for the following IOLs: Sulcoflex Aspheric C-flex Aspheric Superflex Aspheric M-flex T Multifocal Toric Milestone one: Sulcoflex Aspheric Supplementary IOL: A solution to

For immediate release. Date: 17 October, 2017. Surgeons in India to access RayOne fully preloaded IOL injection system. British IOL manufacturer, Rayner, announced today that their new RayOne fully preloaded IOL injection system has received Central Drugs Standard Organisation (CDSCO) approval and is being launched in India. Product approval details The CDSCO granted regulatory approval and sale

For immediate release. Date: 11 July, 2017. RayOne Fully Preloaded IOL Injection System. Now available in Brazil. More surgeons to access the smallest Fully Preloaded IOL Incision Rayner announced today the latest update in the RayOne story: registration of the RayOne Aspheric and Spheric monofocal fully preloaded IOL injection systems has been listed in the Federal Register

For immediate release. March 02, 2017 – Worthing, United Kingdom. Rayner announced today that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chinese Food and Drug Administration (CFDA) approval and are to be launched in market in 2017. Rayner is the first manufacturer to make a supplementary IOL available to surgeons in

For over a decade, the annual Rayner Forum has been a calendar highlight for surgeons in Austria and Germany. However to coincide with the opening of Rayner’s brand new, state of the art headquarters and production facility ‘The Ridley Innovation Centre’ in Worthing, West Sussex, we decided to hold the 2016 Forum in the UK

Rayner’s growth strategy continues as the company announced today that the Egyptian Ministry of Health has approved the following IOLs for sale in Egypt: C-flex Aspheric monofocal IOL range (970C) Superflex Aspheric monofocal IOL range (920H) T-flex Aspheric Toric IOL (573T and 623T) Sulcoflex Pseudophakic Supplementary Aspheric IOL (653L)  Rayner’s unique system package means that in addition to an

Rayner, the pioneering manufacturer of intraocular lenses for cataract surgery, has been named as one of the country’s top ten companies in achieving sustained growth in international turnover. Accountancy and business advisory firm BDO LLP’s analysis of the mid-market (companies with turnover between £10 m – 300 m) has shown that Rayner is one of

The 2015 meeting of the European Society of Cataract and Refractive Surgeons (ESCRS) held in Barcelona, Spain, featured a number of presentations describing surgeons’ experience with Rayner’s portfolio of lenses including the Sulcoflex, C-flex, M-flex and T-flex. The Sulcoflex Pseudophakic Supplementary IOL Supplementary IOLs Versus Wavefront-Guided LASIK for the Correction of Refractive ErrorsTiago Ferreira, MDDr Ferreira described

Professor Oliver Findl, Dr Nino Hirnschall and Professor Michael Amon hosted Rayner’s recent DFP-certified Premium IOL Wetlab event in Vienna, Austria in September 2015. The group of enthusiastic junior surgeons were exposed to a full Toric and Supplementary (Sulcoflex) program which consisted of the following key topics: • Introduction to astigmatism correction • The history of astigmatism correction •

At the 2015 meeting of the European Society of Cataract and Refractive Surgeons Rayner hosted a Satellite Symposium featuring the topic of refractive surprise. The session was introduced and moderated by Prof. Rudy Nuijts, who highlighted that refractive surprise is a serious challenge in cataract and refractive surgery and requires further thought for management. The